美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Inspire Corporate Bond ETF

24.08

+0.06000.25%

盤後：24.080.00000.00%16:10 EDT

成交量：5.85萬

成交額：140.72萬

市值：4.02億

市盈率：- -

高：24.10

開：24.04

低：24.03

收：24.02

52周最高：25.49

52周最低：22.84

股本：1,670.14萬

流通股本：1,670.14萬

量比：0.81

換手率：0.35%

股息：1.00

股息率：4.15%

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞

恆瑞醫藥的新爆點

新藥數據驚豔，美股Abivax暴漲586%，能否打破"燒錢魔咒"？

腾讯自选股

年虧上億、估值39億！張和勝夫婦持股46.5%的和美藥業赴港IPO

和美藥業IPO：商業化前景難言樂觀核心管線臨牀數據顯著弱於競品

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/IBD"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IBD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBD\",,,,,undefined,":{"symbol":"IBD","market":"US","secType":"STK","nameCN":"Inspire Corporate Bond ETF","latestPrice":24.08,"timestamp":1755633600000,"preClose":24.02,"halted":0,"volume":58495,"hourTrading":{"tag":"盘后","latestPrice":24.08,"preClose":24.08,"latestTime":"16:10 EDT","volume":7,"amount":168.58,"timestamp":1755634203943},"delay":0,"floatShares":16701399,"shares":16701399,"eps":0,"marketStatus":"未開盤","change":0.06,"latestTime":"08-19 16:00:00 EDT","open":24.04,"high":24.0994,"low":24.033,"amount":1407153.301336,"amplitude":0.002764,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1755676800000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":24.02,"sharesOutstanding":16900000,"nav":24.02,"aum":405925292.89,"dividendRate":0.041528,"bidAskSpread":0.001129,"postHourTrading":{"tag":"盘后","latestPrice":24.08,"preClose":24.08,"latestTime":"16:10 EDT","volume":7,"amount":168.58,"timestamp":1755634203943},"volumeRatio":0.80821},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBD\",,,,,undefined,":{"symbol":"IBD","floatShares":16701399,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.80821,"shares":16701399,"dividePrice":1,"high":24.0994,"amplitude":0.002764,"preClose":24.02,"low":24.033,"week52Low":22.84,"pbRate":"--","week52High":25.49,"institutionHeld":0,"latestPrice":24.08,"eps":0,"divideRate":0.041528,"volume":58495,"delay":0,"ttmEps":0,"open":24.04,"prevYearClose":23.44,"prevWeekClose":24.06,"prevMonthClose":23.92,"prevQuarterClose":24.01,"fiveDayClose":24.02,"twentyDayClose":24.06,"sixtyDayClose":23.67},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBD\",params:#limit:5,,,undefined,":[{"date":"2025-07-25","symbol":"IBD","amount":0.0806,"announcedDate":"2025-07-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-07-25","defaultRemindTime":1753450200000,"name":"Inspire Corporate Bond ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-30","payableDate":"2025-07-25","currency":"USD","dateTimestamp":1753416000000,"payDate":"2025-07-30"},{"date":"2025-06-26","symbol":"IBD","amount":0.0953,"announcedDate":"2025-06-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-26","defaultRemindTime":1750944600000,"name":"Inspire Corporate Bond ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-26","currency":"USD","dateTimestamp":1750910400000,"payDate":"2025-07-01"},{"date":"2025-05-23","symbol":"IBD","amount":0.0809,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-05-23","defaultRemindTime":1748007000000,"name":"Inspire Corporate Bond ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-05-28","payableDate":"2025-05-23","currency":"USD","dateTimestamp":1747972800000,"payDate":"2025-05-28"},{"date":"2025-04-25","symbol":"IBD","amount":0.0799,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-04-25","defaultRemindTime":1745587800000,"name":"Inspire Corporate Bond ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-30","payableDate":"2025-04-25","currency":"USD","dateTimestamp":1745553600000,"payDate":"2025-04-30"},{"date":"2025-03-27","symbol":"IBD","amount":0.092,"announcedDate":"2025-03-26","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-27","defaultRemindTime":1743082200000,"name":"Inspire Corporate Bond ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-27","currency":"USD","dateTimestamp":1743048000000,"payDate":"2025-04-01"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBD\",market:\"US\",,,undefined,":[{"executeDate":"2017-08-16","recordDate":"2017-08-18","paymentDate":"2017-08-23","value":0.0405,"currency":"USD"},{"executeDate":"2017-09-18","recordDate":"2017-09-19","paymentDate":"2017-09-25","value":0.0292,"currency":"USD"},{"executeDate":"2017-10-16","recordDate":"2017-10-17","paymentDate":"2017-10-23","value":0.0347,"currency":"USD"},{"executeDate":"2017-11-16","recordDate":"2017-11-17","paymentDate":"2017-11-28","value":0.0389,"currency":"USD"},{"executeDate":"2018-01-29","recordDate":"2018-01-30","paymentDate":"2018-02-05","value":0.0269,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBD\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBD\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2560920343","title":"恆瑞醫藥的新爆點","url":"https://stock-news.laohu8.com/highlight/detail?id=2560920343","media":"药渡","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560920343?lang=zh_tw&edition=fundamental","pubTime":"2025-08-17 07:31","pubTimestamp":1755387091,"startTime":"0","endTime":"0","summary":"近期，恒瑞医药又拿下一笔BD大单：将PDE3/4抑制剂HRS-9821的海外权益以及11个创新项目的独家选择权授权给葛兰素史克，将有望获得潜在总交易额125亿美元。这一利好消息，让恒瑞医药A股涨停，总市值成功突破4000亿元大关，H股的总市值更是一度超过5600亿港元。此次BD合作，再次验证了恒瑞在免疫和呼吸系统疾病领域的研发实力。恒瑞这两款重磅新药若想突围而出，面临着不小的压力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250817073528a48ceda7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250817073528a48ceda7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","GSK","BK4007","IBD","GSK.UK","BK4532","LU1829250122.USD","BK4585"],"gpt_icon":0},{"id":"2553522150","title":"新藥數據驚豔，美股Abivax暴漲586%，能否打破\"燒錢魔咒\"？","url":"https://stock-news.laohu8.com/highlight/detail?id=2553522150","media":"腾讯自选股","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553522150?lang=zh_tw&edition=fundamental","pubTime":"2025-07-24 08:37","pubTimestamp":1753317439,"startTime":"0","endTime":"0","summary":"美东时间7月23日，美股生物技术公司Abivax股价盘初一度暴涨超596%，最终收涨586%，最新市值43.48亿美元。消息面上，Abivax宣布，其首创新型口服miR-124增强剂Obefazimod在中度至重度溃疡性结肠炎的ABTECT 8周诱导试验中取得积极的III期结果。单押miRNA疗法2023年6月份，Abivax递交的obefazimod临床试验申请获CDE受理。不过，药物正式获批上市前，Abivaxs是否能凭借单一候选药物冲出重围仍未可知。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724082621971acd29&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724082621971acd29&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IBD","BK4139","ABVX"],"gpt_icon":1},{"id":"2545643811","title":"年虧上億、估值39億！張和勝夫婦持股46.5%的和美藥業赴港IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2545643811","media":"财中社","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545643811?lang=zh_tw&edition=fundamental","pubTime":"2025-06-22 09:37","pubTimestamp":1750556220,"startTime":"0","endTime":"0","summary":"张氏夫妇掌握46.51%股权，董秘系实控人侄女婿从股权结构看，61岁的张和胜端坐权力中心。招股书显示，张和胜通过赣州和胜、赣州和毅控制25.22%投票权；其妻郭雪梅通过香港和美控制21.29%，夫妇合计掌控46.51%股权。在2024年亏损1.23亿元的情况下，公司薪酬单引人注目。张和胜2024年总薪酬达1024万元，其中基本薪资120.1万元，以股份为基础的支付830.4万元。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/zqgd/2025-06-22/doc-infaxhkr0770766.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IBD"],"gpt_icon":0},{"id":"2543814726","title":"和美藥業IPO：商業化前景難言樂觀 核心管線臨牀數據顯著弱於競品","url":"https://stock-news.laohu8.com/highlight/detail?id=2543814726","media":"新浪证券","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543814726?lang=zh_tw&edition=fundamental","pubTime":"2025-06-13 19:52","pubTimestamp":1749815520,"startTime":"0","endTime":"0","summary":"　　近日，和美药业向港交所提交上市申请，拟根据上市规则第18A章在香港主板挂牌上市，国证国际为其独家保荐人。尽管公司核心管线已步入后期临床，但对公司招股书等相关资料进行梳理后发现，公司核心管线临床数据显著弱于竞品或市场规模有限，未来的商业化之路仍面临挑战。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/observe/2025-06-13/doc-inezxtpe6365499.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["03347","IE00BVYPNW00.USD","LU1066051811.HKD","LU2505996509.AUD","BK4550","IE00BFXG1179.USD","BK4568","LU0345769631.USD","LU0466842654.USD","LU0985320562.USD","LU2133065610.SGD","BK4007","LU1221951129.SGD","LU2129689605.HKD","ADC","BK4585","LU1718418525.SGD","IE00BJT1NW94.SGD","LU2602419157.SGD","LU0912757837.SGD","IE0009355771.USD","LU1732800096.USD","IE0002270589.USD","IE00BBT3K403.USD","LU0098860793.USD","LU0289739699.SGD","LU0058720904.USD","LU1267930813.SGD","JNJ","IE00BFTCPJ56.SGD","IE00B42XCP33.USD","LU0795875086.SGD","LU2089984988.USD","LU1280957306.USD","IBD","LU0640476718.USD","BK4592","IE00B3PB1722.GBP","LU0203345920.USD","LU1244550494.USD","LU2430703178.SGD","LU0345770993.USD","IE00B19Z3581.USD","SG9999002232.USD","LU1023059063.AUD","LU0345769128.USD","BK4534","IE0002141913.USD","LU1032466523.USD","LU2430703095.HKD"],"gpt_icon":0}],"pageSize":4,"totalPage":7,"pageCount":1,"totalSize":25,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/IBD\",params:#limit:6,delay:false,,,undefined,":[]}}